| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8730773 | Pancreatology | 2017 | 36 Pages |
Abstract
RFA provides a minimally invasive and safe treatment for patients with pancreatic cancer with liver oligometastases. The clinical efficiency of RFA for hepatic oligometastatic pancreatic cancer was easily affected by the following factors: primary tumor location, maximum diameter of liver metastasis and NLR. These factors could be helpful for treatment decision and clinical trial design.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Yong-Qiang Hua, Peng Wang, Xiao-Yan Zhu, Ye-Hua Shen, Kun Wang, Wei-Dong Shi, Jun-Hua Lin, Zhi-Qiang Meng, Zhen Chen, Hao Chen,